Front Range Biosciences Stock
Agricultural science for cannabis and hemp
Sign up today and learn more about Front Range Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Front Range Biosciences Stock
CEO: Jon Vaught, PhD, Organic Chemistry, CU Boulder, 10 years biotech startup experience with 4 companies CSO: Chris Zalewski, PhD, Plant Biology, UC Davis, 20 years plant biotechnology experience COO: Nick Hofmeister, MBA, MIT, raised $250 million, co-founder 4 biotech companies Problem: Due to 60 years of prohibition, cannabis and hemp cultivators don’t have access to the bioscience tools that are used in modern agriculture. Cannabis and hemp growers are losing money due to disease, reduced yields, and un-differntiated product. Solution: Use known agricultural biotechnology (e.g., tissue culture, cryopreservation, analytical chemistry, genomics and marker assisted breeding) to improve yields, reduce disease, and create novel strains.
Funding History
March 2016 | $20K |
---|---|
May 2016 | $50K |
February 2017 | $1.5M |
September 2017 | $3.0M |
October 2018 | $10.0M |
Management
CEO, Founder
Jonathan Vaught
COO, Founder
Nick Hofmeister
CSO, Founder
Christopher Zalewski
Press
patents - Apr, 13 2024
Characterization of cannabis cultivars based on terpene synthase gene profilespatents - Apr, 13 2024
Cannabis plant named 'lpa004'patents - Apr, 13 2024
Compositions and methods for obtaining plant cultivars with desired terpene …patents - Apr, 13 2024
Cannabis plant named 'frb005'patents - Apr, 13 2024
Methods and compositions for pathogen detection in plants